Let me say a few words, then I will let my colleague take over.
First of all, thank you for the question, Ms. Lambropoulos.
I feel that choosing Novavax for Canada is very good news for Canadians. As I often say, we must act immediately and concretely, yet with a long-term vision. What is our long-term vision? It is to ensure the health and safety of Canadians, and that requires resilience and caution.
My role as Minister of Innovation, Science and Industry is to bring home as many links in the supply chain as possible. As noted in the previous questions, we have realized that we are starting from a reduced manufacturing base. This began decades ago. What we are doing now is rebuilding the biomanufacturing base here at home. This will allow us to face the future with much more resilience.
Together with the NRC and its president, Mr. Davies, we will do everything we can to accelerate the construction of the Royalmount Avenue plant. We have four stages: design, construction, certification and production. We are going to do everything we can to make it happen quickly.
That being said, we have other pillars, such as Medicago in Quebec City, AbCellera in Vancouver and VIDO in Saskatchewan.
What I am doing, in cooperation with the government and public servants, is laying the foundations of this resilience, so that Canada is stronger and can face any future health emergency.